FIGS

ANALYST NOTE: FIGS, INC. (FIGS) DATE: 2026-06-13 CURRENT PRICE: $12.31

1. Structural Readiness

State: Context-Only Conservative Entry: — Breakout Level: — Extension: — ATR Current: 5.6% (High)

Structural Assessment:

2. Thesis Layer

Thesis Classification: TACTICAL / Setup-Led Secular Exposure: None Named

At this date, FIGS is not anchored to a named macro or secular thesis within the StoryStocks framework. The investment case is strictly tactical and setup-led. The conviction must be derived entirely from the quality of the business fundamentals and the eventual formation of a technical structure, rather than a pre-existing macro narrative. There is no "secular-theme exposure" to weight the conviction at this specific moment. The analyst must judge the name solely on the strength of the operational data provided in the recent earnings and filings, treating the lack of a named thesis as a neutral factor that requires the setup to carry the full weight of the conviction.

3. The Business

Company Profile: FIGS, Inc. operates as a founder-led, direct-to-consumer (DTC) enterprise specializing in healthcare apparel and lifestyle merchandise. The company functions within the Consumer Discretionary sector, specifically targeting the healthcare and social assistance industry.

Business Model & Operations:

• Product Strategy: The company sells medical uniforms (scrubs) and non-scrub lifestyle items. As of the 2025 Annual Report context, 17 core scrubwear styles represented over 60% of net revenues in 2025. The strategy focuses on "de-commoditizing" a previously unbranded industry by elevating product quality and brand resonance.
• Distribution: Sales are executed primarily through an integrated digital platform (website and mobile app). The company also operates five physical retail locations termed "Community Hubs," with plans to expand this footprint.
• Customer Base: The company serves a diverse range of healthcare professionals, including nurses, surgeons, dentists, pharmacists, and veterinarians. As of March 31, 2026, the company reported approximately 3.0 million active customers, marking a 12.2% year-over-year expansion from 2.7 million in the prior year.

Financial Performance (Source: Earnings Transcript & 10-K, dated 2026-05-07):

• Revenue Growth: For the quarter ended March 31, 2026, net revenues increased 28% year-over-year to $159.9 million, significantly outpacing the prior outlook of low 20% growth.
• Guidance Revision: Management has raised full-year 2026 net revenue growth expectations to 14–16%, up from a prior range of 10–12%.
• Margin Expansion:
• Operating Margin: Raised to 7.8%–8.0% (from 7.6%–7.9%).
• Adjusted EBITDA Margin: Raised to 13.0%–13.2% (from 12.7%–12.9%).
• Q1 Adjusted EBITDA: Increased to $13.9 million (from $9.2 million), representing an 8.7% margin.
• Tariff Mitigation: The company has applied for a refund of approximately $20 million in IEEPA tariffs paid. Management notes that while tariffs will continue to negatively impact gross margin for 2026, the impact is expected to be less severe than previously disclosed in the 2025 10-K.

4. Archetype and Conviction Stack

Archetype: Growth Leader / Margin Inflector FIGS fits the archetype of a Growth Leader that is simultaneously executing a Margin Inflector strategy. The company is demonstrating top-line acceleration (28% Q1 growth, raised FY guidance) while expanding profitability (EBITDA margin expansion to ~8.7% in Q1, raised full-year guidance).

Conviction Stack Analysis:

• Thesis Strength: Low (No named secular thesis; purely tactical).
• Evidence Quality: High. The evidence block is robust, featuring multiple primary sources (earnings transcripts, 10-K filings) from May 2026 that confirm revenue beats, margin expansion, and customer base growth.
• Structural Quality: Neutral/Unknown. The structural setup is currently undefined (context-only). The high ATR (5.6%) suggests active trading interest but does not confirm a trend.
• Rerating Potential: Moderate to High. The combination of raised guidance, margin expansion, and a growing customer base (3M active users) provides a fundamental basis for a rerating, provided the technical structure forms.

Valuation Context: The financial spine indicates a forward consensus EPS of $0.26238 for FY1 and $0.32013 for FY2. At a current price of $12.31, the stock trades at approximately 47x FY1 EPS and 38x FY2 EPS. This valuation implies a high growth premium, consistent with the "Growth Leader" archetype, but requires the continued execution of the raised guidance to justify.

5. Invalidation, Strengthening, and Gaps

What Would Strengthen the Case:

• Continued Margin Expansion: Management maintaining or further expanding the raised EBITDA margin guidance in subsequent quarters, proving the tariff mitigation is effective.
• Customer Retention: Evidence that the 3.0 million active customer base is growing at an accelerating rate or showing increased lifetime value (LTV).

What Would Invalidate the Case:

• Guidance Miss: A failure to meet the raised 14–16% full-year revenue growth or a contraction in operating margins would contradict the current "Growth Leader" narrative.
• Tariff Escalation: If the IEEPA tariff refund is denied or if tariffs increase further, negating the margin improvement, the thesis would be materially weakened.

Gaps in Evidence Base:

• Inventory/Supply Chain: While tariffs are mentioned, there is no specific evidence in the provided block regarding inventory levels, supply chain lead times, or specific mitigation strategies beyond the tariff refund application.
• Competitive Landscape: No specific data on market share gains relative to competitors or new entrants is provided in the evidence block.

PRIVATE ANALYST CALL

Judgment: Speculative Confidence: medium Key evidence: Q1 revenue grew 28% to $159.9M beating low-20% guidance; Management raised full-year revenue growth to 14-16% and EBITDA margin to 13-13.2%; Active customer base reached 3.0 million, up 12.2% YoY. Expected path: Management expects continued revenue acceleration and margin expansion; the stock likely requires a technical breakout to validate the fundamental strength and attract institutional flow. Expected horizon: 3 to 6 months for a structural setup to form and resolve.